Menstrual Blood Stem Cells Used to Treat Heart Failure Patients Marketwire (press release) The RECOVER-ERC trial is a 60 patient, double-blind, placebo controlled study in which patients with congestive heart failure are divided into 3 groups, which receive ERC in a dose escalating manner of 50, 100,and 200 million cells. ... We believe ERC ... |
